Testing laboratory · Reviewed 2026-09-03
ILS Labs Inc. / ILS Analytical LLC · San Diego, California, USA
Legitimacy review
ILS is a legitimate operating laboratory with a staffed San Diego facility and active ISO/IEC 17025 accreditation. Its confirmed accreditation scope is cannabis-specific rather than peptide-specific, and its peptide program has material recent service and report-control concerns.
Official terms separate ILS Labs Inc., the testing entity, from ILS Analytical LLC, the platform, billing, and client-services entity at 8222 Vickers St, Suite 106, San Diego. The accreditation names ILS Labs, Inc. dba Quality Cannabis Laboratories.
Current accreditation record, operating address, public terms, laboratory walkthrough, equipment, staff, LIMS, and a large recurring issued-report corpus.
PJLA accreditation 112120, certificate L25-631, is valid through August 31, 2027. The reviewed scope lists cannabis matrices and methods; it does not expressly list peptide purity, identity, quantity, endotoxin, or sterility assays.
Official materials offer HPLC, LC-MS, GC-MS, ICP-MS, endotoxin, rapid sterility, stability, and method development. The official target is roughly one week; a June 2026 facility walkthrough described a recently expanded peptide workflow and acknowledged scaling and method-development challenges.
The supplied Reddit thread includes repeated three-to-four-week delay, missed-date, communication, and paperwork complaints, plus customers who ultimately received results and valued the price. PeptideCritic separately documented contradictory issued-report fields and a wrong image, while expressly not alleging fabricated chromatography.
Accreditation scope does not establish accredited peptide testing; recent service and report-QC evidence raises substantive concerns. The walkthrough is a third-party narrated visit, not an independent PeptidePrices inspection. Customer posts are anecdotal and cannot establish analytical validity by themselves.
ILS is not an anonymous certificate brand. Its terms distinguish ILS Labs Inc., the analytical-testing entity, from ILS Analytical LLC, which operates the platform, billing, and client-service layer at the San Diego address. The published PJLA record names ILS Labs, Inc. dba Quality Cannabis Laboratories.
PJLA certificate L25-631 is current through August 31, 2027, but its published scope covers cannabis matrices and listed methods. Peptide purity, identity, quantity, endotoxin, and sterility do not appear expressly in that scope. The accurate conclusion is that ILS operates an accredited laboratory with a peptide program outside the peptide-specific scope confirmed in this review.
A June 2026 walkthrough shows a working San Diego facility with staff, analytical instruments, laboratory information systems, intake activity, and a peptide workflow that was being expanded. That is strong evidence that ILS is a real operating laboratory rather than a report-only issuer.
The same walkthrough described scaling and method-development pressure. Facility evidence establishes an operating lab and visible workflow; it does not independently validate every peptide measurement or extend the cannabis accreditation scope to peptide assays.
PeptideCritic documented an issued MOTS-C report containing an unrelated dog image and another report with internally contradictory language around failure and 100% purity. A separate zero-control report was correctly failed. Together, those examples point to report assembly and quality-control weaknesses, not proof that the underlying chromatography was fabricated.
For buyers evaluating ILS, the practical question is therefore two-part: whether the access code returns the official record, and whether every field, image, panel, and conclusion inside that record agrees. Issuer verification alone does not cure an internally inconsistent report.
The supplied Reddit discussion includes repeated reports of three-to-four-week waits, missed completion dates, weak communication, and paperwork problems. Other customers reported eventually receiving results and valued ILS pricing. Those accounts describe service delivery during a specific growth period; they are not analytical proficiency data.
The strongest current conclusion is specific: ILS has substantial operating evidence and a functioning peptide program, but its peptide accreditation language must remain qualified and its recent turnaround and report-control record warrants scrutiny.
COA verification
Enter the certificate's access code in the official verifier, then compare the COA number, client, sample, lot, dates, and panels with the retained document.
Result handling
Use only when the official destination returns the same identifier and the material certificate fields agree.
Use only after a functioning official lookup explicitly returns no record for the submitted identifier.
Use when the official destination resolves the identifier but returns a different report, product, batch, or other material identity field.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Not applicable to the current ILS adapter; use unresolved when the access code is missing or unreadable.
Use when the issuer identity, required identifier, or official workflow cannot be established from the available evidence.
Certificate structure
Retain and display every page in order. ILS reports in the corpus range from 1 to 4 pages and frequently place different panels on separate pages.
Preserve purity, identity, content, heavy metals, sterility, endotoxin, and other assays as separate results; an 'all assays passed' summary does not replace the underlying panel data.
Evidence boundaries
Review receipts
Public search record
Current results combine the official lab and verifier with active Reddit discussion about service, accreditation scope, and analytical confidence. The review opportunity is to anchor the page in the official access-code workflow while clearly labeling community claims as unverified commentary.
Sources
Reusable integration rule: For future vendors, retain both the ILS access code and COA number, capture the QR destination when present, preserve every panel page, and compare lot and sample identity before product matching.
Frequently asked questions
Qualified yes. ILS is a legitimate operating laboratory with a staffed San Diego facility and active ISO/IEC 17025 accreditation. Its confirmed accreditation scope is cannabis-specific rather than peptide-specific, and its peptide program has material recent service and report-control concerns.
Official materials offer HPLC, LC-MS, GC-MS, ICP-MS, endotoxin, rapid sterility, stability, and method development. The official target is roughly one week; a June 2026 facility walkthrough described a recently expanded peptide workflow and acknowledged scaling and method-development challenges.
ISO/IEC 17025 — cannabis scope. PJLA accreditation 112120, certificate L25-631, is valid through August 31, 2027. The reviewed scope lists cannabis matrices and methods; it does not expressly list peptide purity, identity, quantity, endotoxin, or sterility assays.
Enter the certificate's access code in the official verifier, then compare the COA number, client, sample, lot, dates, and panels with the retained document.
The reviewed sources did not establish that vendors can purchase a passing result from ILS Laboratories. That is not an audited independence guarantee: sample selection, who pays, publication rights, blind-testing controls, and correction history still matter.
Physical-vial custody is unknown unless a documented chain connects the tested sample to the specific vial in hand.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Check the document
